Determination of human absorbed dose of 201Tl(III)-DTPA-HIgG based on biodistribution data in rats

Radiation Protection Dosimetry

Volumn 141, Issue 3, 2010, Pages 269-274

  Moghaddam, Alireza Khorrami ^a   Jalilian, Amir Reza ^b   Hayati, Vali ^c   Shanehsazzadeh, Saeed ^d  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Engineering Research Institute   (Iran)

^c Mohammad Bagher University   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; ISOTOPE; PENTETIC ACID; THALLIUM;

ADRENAL GLAND; ANIMAL; ARTICLE; CHEMISTRY; HUMAN; INFLAMMATION; KIDNEY; LIVER; METABOLISM; METHODOLOGY; MUSCLE; RADIATION EXPOSURE; RADIOMETRY; RAT; SPLEEN; TIME;

ADRENAL GLANDS; ANIMALS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; ISOTOPES; KIDNEY; LIVER; MUSCLES; PENTETIC ACID; RADIOMETRY; RATS; SPLEEN; THALLIUM; TIME FACTORS;

EID: 77957279922     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncq172     Document Type: Article

References (24)

1. 67GA-DTPA-ACTH based on distribution data in rats. Radiat. Prot. Dosim. 134, 79-86 (2009).
2. 201Tl](III)-DTPA-human polyclonal antibody complex for inflammation detection. Radiochim. Acta. 95.11.669 (2007).
3. Jalilian, A. R., Bineshmarvasti, M. and Sardari, S. Application of radioisotopes in inflammation. Curr. Med. Chem. 13, 959 (2006).
4. Villaverde, M. S. and Verstraeten, S. V. Effects of thallium(I) and thallium(III) on liposome membrane physical properties. Arch. Biochem. Biophys. 417, 235 (2003).
5. ICRP Publication 23. International Commission on Radiological Protection. Report of task group on reference man. ICRP Publication 23 (New York: Pergamon Press) (1993).
6. International Commission on Radiological Protection. Radiological Protection in Biomedical Research. ICRP Publication 62. Ann. ICRP 22(3) (1993).
7. Sparks, R. B. and Aydogan, B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. In: Sixth International Radiopharmaceutical Dosimetry Symposium. S-Stelson, A.T., Stabin, M.G. and Sparks, R.B. Eds. (Oak Ridge, TN: Oak Ridge Associated Universities) pp. 705-716 (1996).
8. Cristy, M. and Eckerman, K. Specific Absorbed Fractions of Energy at Various Ages from Internal Photons Sources (Oak Ridge, TN: Oak Ridge National Laboratory) (1987).
9. Peters, J. M. and Boyd, E. M. Organ weights and water levels of the rat following reduced food intake. J. Nutr. 90, 354-60 (1966).
10. Snyder, W. S., Ford, M. R., Warner, G. G. and Watson, S. B. 'S' absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No.11 (New York, NY: Society of Nuclear Medicine) (1975).
11. Snyder, W. S., Ford, M. R. and Warner, G. G. Estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous phantom. MIRD Pamphlet No. 5, revised (New York, NY: Society of Nuclear Medicine) (1978).
12. International Commission on Radiation Units and Measurements. Methods of assessment of absorbed dose in clinical use of radionuclides. Report No. 32 (Washington, DC: ICRU) (1979).
13. National Council on Radiation Protection and Measurements. The experimental basis for absorbed dose calculations in Medical Uses of Radionuclides. Report No. 83 (Bethesda, MD: NCRP) (1985).
14. Loevinger, R., Budinger, T. F. and Watson, E. E. MIRD Primer for Absorbed Dose Calculations (New York: Society of Nuclear Medicine, Inc) (1988).
15. Jalilian, A. R., Akhlaghi, M., Aboudzadeh, R., Shirazi, B., Raisali, G., Salouti, M. and Babaii, M. [201Tl](III)-Bleomycin for tumor imaging. Radiochim. Acta. 94, 453 (2006).
16. Schmitt, A., Bernhardt, P., Nilsson, O., Ahlman, H., Kölby, L., Schmitt, J. and Forssel-Aronsson, E. Biodistribution and dosimetry of 177Lu-labeled [DOTA0,Tyr3] octreotate in male nude mice with human small cell lung cancer. Cancer Biother. Radiopharm. 18, 593-599 (2003).
17. De Jong, M. et al. [177Lu-DOTA0, Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy. Int. J. Cancer 1, 628-633 (2001).
18. Lewis, J., Wang, M., Laforest, R., Wang, F., Erion, J., Bugaj, J., Srinivasan, A. and Anderson, C. Toxicity and dosimetry of 177Lu-DOTA-Y3-octreotate in a rat model. Int. J. Cancer 94, 873 (2001).
19. Palm, S., Enmon, R. M., Matei, C., Kolbert, K. S., Xu, S., Zanzonico, P. B., Finn, R. L., Koutcher, J. A., Larson, S. M. and Sgouros, G. Pharmacokinetics and biodistribution of (86)Y-trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlativeMicroPETand MRI. J. Nucl.Med. 44, 1148-1155 (2003).
20. Deterding, T. A., Voraw, J. R., Wang, C. K., Eshima, D., Eshima, L., Keil, R., Malveaux, E., Kilts, C. D., Goodman, M. M. and Hoffman, J. M. Biodistribution and radiation dosimetry of the dopamine transporter ligand. J. Nucl. Med. 42, 376-381 (2001).
21. Bélanger, M. J., Krause, S. M., Ryan, C., Sanabria-Bohorquez, S., Li, W., Hamill, T. G. and Burns, H. D. Biodistribution and radiation dosimetry of [18F] F-PEB in nonhuman primates. Nucl. Med. Commun. 29(10), 915-919 (2008).
22. Kesner, A. L., Hsueh, W. A., Czernin, J., Padgett, H., Phelps, M. E. and Silverman, D. H. Radiation dose estimates for [(18) F] 5-fluorouracil derived from PET-based and tissue-based methods in rats. Mol. Imaging Biol. 10(6), 341-348 (2008).
23. 201T1(III) DPTA-neurotensin (8-13). J. Labelled Comp. Radiopharm. 43, 1227 (2000).
24. Vázquez, D. M., Morano, M. I., Taylor, L. and Akil, H. Kinetics of radiolabeled adrenocorticotropin hormone in infant and weanling rats. J. Neuroendocrinol. 9, 529-536 (1997).